1Herrler A, Beier HM. Early embryonic coats: morphology,function, practical applications. An overview. Cells Tissues Or gans 2000,166: 233-246.
2Leach RE, Khalifa R, Ramirez ND, et al. Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab,1999,84:
3Yoo HJ, Barlow DH, Mardon HJ, et al. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet, 1997,21:102-108.
4Raab G, Kover K, Paria BC, et al. Mouse preimplantation blastocysts adhere to cells expressing the transmembrane form of heparin-binding EGF-like growth factor. Development, 1996, 122:637-645.
5Nakamura K, Mitamura T, Takahashi T, et al. Importance of the major extracellular domain of CD9 and the epidermal growth factor (EGF)-like domain of heparin-binding EGF-like growth factor for up-regulation of binding and activity. J Biol Chem,2000, 275:18
6Pillai SB, Luquette MH, Nowicki PT, et al. Heparin-binding EGF-like growths factor reduces intestinal injury after Ischemia.Mol Bio Cell, 1997, 8: 8a.
7Richard E, Leach, Reda K, et al. Multiple roles for heparinbinding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab, 1999,84:3355-33
8Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today, 1997, 18:478-482.
